Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.

Quirk SK, Shure AK, Agrawal DK

Open source

DOI
10.1016/j.trsl.2015.06.005
Published
2015 Nov
Container
Translational research : the journal of laboratory and clinical medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.trsl.2015.06.005,
  title = {Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.},
  author = {Quirk SK and Shure AK and Agrawal DK},
  year = {2015},
  journal = {Translational research : the journal of laboratory and clinical medicine},
  doi = {10.1016/j.trsl.2015.06.005},
  url = {https://doi.org/10.1016/j.trsl.2015.06.005}
}

RIS

TY  - JOUR
TI  - Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.
AU  - Quirk SK
AU  - Shure AK
AU  - Agrawal DK
PY  - 2015
JO  - Translational research : the journal of laboratory and clinical medicine
DO  - 10.1016/j.trsl.2015.06.005
UR  - https://doi.org/10.1016/j.trsl.2015.06.005
ER  - 

APA

SK, Q., AK, S., & DK, A. (2015). Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.. Translational research : the journal of laboratory and clinical medicine. https://doi.org/10.1016/j.trsl.2015.06.005

Source records